Biblio
Export 1181 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is D [Clear All Filters]
“Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 231-42, 2015.
, “Successful Object Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1195-1205, 2017.
, “Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1183-1202, 2021.
, “Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications.”, J Alzheimers Dis, vol. 60, no. 3, pp. 783-794, 2017.
, “A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1471-1481, 2018.
, “A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1471-1481, 2018.
, “A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1359-1379, 2017.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “TAR DNA-Binding Protein 43 Is Associated with Rate of Memory and Functional and Global Cognitive Decline in the Decade Prior to Death.”, J Alzheimers Dis, vol. 80, no. 2, pp. 683-693, 2021.
, “Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?”, J Alzheimers Dis, vol. 57, no. 2, pp. 493-504, 2017.
, “Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.”, J Alzheimers Dis, vol. 64, no. s1, pp. S427-S453, 2018.
, “Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.”, J Alzheimers Dis, vol. 64, no. s1, pp. S427-S453, 2018.
, “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
, “Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 4, pp. 965-75, 2015.
, “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
, “TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1227-1233, 2018.
, “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
, “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
, “Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.”, J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
, “Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.”, J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
, “Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 985-994, 2018.
,